Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Amgen : To Present At The Goldman Sachs 41st Annual Global Healthcare Conference

share with twitter share with LinkedIn share with facebook
06/05/2020 | 04:01pm EDT

THOUSAND OAKS, Calif., June 5, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 41st Annual Virtual Global Healthcare Conference on Wednesday, June 10, 2020 at 1:20 p.m. ET. Peter H. Griffith, executive vice president and chief financial officer, and David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-41st-annual-global-healthcare-conference-301071495.html

SOURCE Amgen


© PRNewswire 2020
share with twitter share with LinkedIn share with facebook
Latest news on AMGEN INC.
07/12AMGEN : Announces Additional Investment In BeiGene
PR
07/12BeiGene to Raise US$2.07 Billion via Share Issuance
DJ
07/10AMGEN : Supplements To Biologics License Application Do Not Trigger New Notice O..
AQ
07/10FEDERAL CIRCUIT : Supplementation Of ABLA Does Not Trigger New Notice Of Commerc..
AQ
07/10"All Substantial Rights" And Right To Prosecute May Be Informative For Assess..
AQ
07/09AMGEN : This Small but Mighty Amgen Facility Set the Bar with Its COVID-19 Respo..
PU
07/09AMGEN : Wins Right To Market Mvasi™ — Federal Circuit Interprets BPC..
AQ
07/02NOVARTIS : Sandoz reviewing options after Federal Circuit upholds lower court ru..
AQ
07/01S&P, Nasdaq close higher on vaccine hopes, improving data
RE
07/01NOVARTIS : Sandoz May Appeal to US Supreme Court in Biosimilar Erelzi Case
DJ
More news